First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)
- Conditions
- Coronary Artery StenosisCoronary Artery Disease
- First Posted Date
- 2013-10-10
- Last Posted Date
- 2020-01-18
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 123
- Registration Number
- NCT01960504
- Locations
- 🇧🇪
OLV-Ziekenhuis Aalst, Aalst, Belgium
🇧🇷Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil
🇧🇷Instituto do Coração - HCFMUSP, São Paulo, Brazil
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-09-11
- Last Posted Date
- 2017-06-26
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 585
- Registration Number
- NCT01939249
- Locations
- 🇦🇺
Fiona Stanley Hospital, Murdoch, Australia
🇦🇺Prince of Wales Hospital Sydney, Sydney, Australia
🇧🇪Gasthuisberg Leuven, Leuven,, Belgium
BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries
- Conditions
- Peripheral Artery DiseaseAtherosclerosisArteriosclerosisVascular Disease
- First Posted Date
- 2013-06-04
- Last Posted Date
- 2015-02-09
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 72
- Registration Number
- NCT01867736
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
🇧🇪Imelda Hospital, Bonheiden, Belgium
🇧🇪A.Z. Sint-Blasius, Dendermonde, Belgium
The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal Stent
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2013-03-15
- Last Posted Date
- 2015-03-24
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 43
- Registration Number
- NCT01811927
- Locations
- 🇳🇱
St. Antonius Hospital, Nieuwegein, Netherlands
🇨🇭University Hospital of Basel, Basel, Switzerland
🇨🇭Kantonsspital St. Gallen, St. Gallen, Switzerland
Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe
- Conditions
- Peripheral Artery DiseasePeripheral Vascular Disease
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2017-02-03
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 456
- Registration Number
- NCT01661231
- Locations
- 🇦🇹
Medical University of Graz, Graz, Austria
🇧🇪Imelda Ziekenhuis, Bonheiden, Belgium
🇧🇪AZ St.-Blasius Hospital, Dendermonde, Belgium
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.
- Conditions
- Coronary RestenosisCoronary Artery Disease
- First Posted Date
- 2012-07-27
- Last Posted Date
- 2016-09-26
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 231
- Registration Number
- NCT01651390
- Locations
- 🇩🇪
Universitäts-Herzzentrum Freiburg-Bad Krozingen, Bad Krozingen, Germany
🇩🇪Heart Center Segeberger Kliniken, Bad Segeberg, Germany
🇩🇪Charité - Universitätsmedizin Berlin, Charité Centrum 11 für Herz-, Kreislauf- und Gefäßmedizin, Berlin, Germany
PROGRESS-AMS 1.0 Clinical Long Term Follow-Up
- Conditions
- Long Term Safety of the AMS 1.0
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2015-02-05
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 55
- Registration Number
- NCT01610102
- Locations
- 🇦🇺
Austin & Repatriation Medical Centre, Heidelberg, Victoria, Australia
🇧🇪O.L.V. Ziekenhuis Aalst, Aalst, Belgium
🇩🇪Westdeutsches Herzzentrum Essen, Essen, NRW, Germany
BIOFLOW-III All-comers Orsiro Safety and Performance Registry
- Conditions
- Coronary Artery DiseaseMyocardial Ischemia
- First Posted Date
- 2012-03-14
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 1356
- Registration Number
- NCT01553526
- Locations
- 🇦🇹
University Hospital Innsbruck, Innsbruck, Austria
🇨🇱Clinica Tabancura, Santiago, Chile
🇩🇰Gentofte Universitets Hospital, Hellerup, Denmark
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2012-02-13
- Last Posted Date
- 2013-03-25
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 202
- Registration Number
- NCT01531725
BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2013-04-04
- Lead Sponsor
- Biotronik AG
- Target Recruit Count
- 120
- Registration Number
- NCT01426139
- Locations
- 🇮🇳
Madras Medical Mission, Chennai, India
🇮🇳Medanta The Medicity Hospital, Gurgaon, India
🇮🇳Max Super Speciality Hospital, New Delhi, India